Evidence map›Paper›PMID 36499104›Full record

ArticleInternational journal of molecular sciences2022

Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.

Sonia Bustamante, Yunki Yau, Victoria Boys, Jeff Chang, Sudarshan Paramsothy, Aviv Pudipeddi, Rupert W Leong, Valerie C Wasinger

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. SARS-CoV-2 virus infection ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. The Impact of Serum/Plasma Proteomics on SARS-CoV-2 Diagnosis and Prognosis.International journal of molecular sciences · 2024
    Review
  7. Dysregulation of CD4Journal for immunotherapy of cancer · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Discovering KYNU as a feature gene in hidradenitis suppurativa.International journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sonia BustamanteBioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, The University of New South Wales, Sydney, NSW 2052, Australia.
Yunki YauDepartment of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.ORCID 0000-0001-8832-8200
Victoria BoysSchool of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0001-6844-2559
Jeff ChangDepartment of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
Sudarshan ParamsothyDepartment of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
Aviv PudipeddiDepartment of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
Rupert W LeongDepartment of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
Valerie C WasingerBioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0001-5338-0869
Concord Repatriation General Hospital · AUThe University of Sydney · AUUNSW Sydney · AU

Funding

Millenium pharmaceutical research grant NA
6 · The paper itself

Abstract

The epithelial barrier's primary role is to protect against entry of foreign and pathogenic elements. Both COVID-19 and Inflammatory Bowel Disease (IBD) show commonalities in symptoms and treatment with sensitization of the epithelial barrier inviting an immune response. In this study we use a multi-omics strategy to identify a common signature of immune disease that may be able to predict for more severe patient outcomes. Global proteomic approaches were applied to transcriptome and proteome. Further semi- and relative- quantitative targeted mass spectrometry methods were developed to substantiate the proteomic and metabolomics changes in nasal swabs from healthy, COVID-19 (24 h and 3 weeks post infection); serums from Crohn's disease patients (scored for epithelial leak), terminal ileum tissue biopsies (patient matched inflamed and non-inflamed regions, and controls). We found that the tryptophan/kynurenine metabolism pathway is a 'hub' regulator of canonical and non-canonical transcription, macrophage release of cytokines and significant changes in the immune and metabolic status with increasing severity and disease course. Significantly modified pathways include stress response regulator EIF2 signaling (

Indexed as

COVID-19Inflammatory Bowel DiseasesHumansInflammationProteomicsTranscriptomeTryptophanTryptophanCOVID-19IBDIFNleaky-gutmitochondrial dysfunctionNADPARPSARS-2tryptophanWARS

Identifiers

PMID36499104
PMCPMC9737535
OpenAlexW4310243837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.